Provide is a Cavβ2 peptide or variant thereof, or synthetic molecules, or polynucleotides encoding said peptide or variant, for use in the modulation of cardiac inotropism. Also provided are compositions and methods of treatment comprising said Cavβ2 peptide, polynucleotide or variants thereof.
